.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
VET CBD is stocked at 279 licensed dispensaries across California, Arizona, and 3 other states, 265 of them in California, with the deepest coverage in Los Angeles, San Diego, Sacramento, La Mesa, and San Francisco. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, VET CBD concentrated 95.38% of sales in Tincture & Sublingual while Edible accounted for 4.62%, indicating a tightly focused mix. Within Tincture & Sublingual, sales were down 5.95% year over year but up 2.85% month over month, whereas Edible declined 11.54% year over year but rose 20.40% month over month. Despite a brand-level year-over-year sales decline of 6.23% alongside an 11.34% year-over-year increase in average price to $49.09, the category split implies reliance on a single core format with limited diversification, and the mixed YoY/MoM signals suggest tactical pricing and recent demand lift are not yet offsetting longer-term softness.
VET CBD’s rank of 3 in Tincture & Sublingual in California, combined with a 95.38% category share of its own mix and a 2.85% month-over-month uptick within that category, implies a defensible position built on depth rather than breadth. However, the 11.34% year-over-year price increase alongside a 5.95% year-over-year decline in its core category and a 16.15% sales drop over 24 months indicates price-led value capture may be pressuring volume, and the 20.40% month-over-month rise in the smaller Edible slice suggests a viable, though still marginal, channel for buffering category concentration risk.
Competitive Landscape
VET CBD sits at rank #3 in California Tincture & Sublingual for October 2026, improving 1 position from #4 year over year, while holding steady at #3 versus three months ago; the peak rank of #3 in October 2026 matches the current standing, indicating stability rather than a surge. Competitively, Papa & Barkley maintained #1 year over year with an 8.27% sales lift, and Yummi Karma is entrenched at #2 with 20.79% YoY growth, whereas Mary's Medicinals climbed from #7 to #4 on 58.13% YoY growth and Care By Design slid from #3 to #5 with a -35.91% YoY decline; this mix implies VET CBD’s flat three-month rank and modest YoY rise place it as a stable #3 that must defend against a fast-climbing #4 while chasing two incumbents with positive momentum.
Notable Products
VET CBD is concentrated in tinctures, with Tincture accounting for 95.4% of October 2026 sales and the top 10 items covering 97.3% of revenue. The leading CBD/THC 20:1 Regular Strength Tincture holds 22.9% alone, so most of its sales ride on a narrow tincture lineup.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
